Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Stoke Therapeutics (STOK)

Stoke Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:STOK
DateTimeSourceHeadlineSymbolCompany
20/05/202421:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STOKStoke Therapeutics Inc
20/05/202421:21Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STOKStoke Therapeutics Inc
17/05/202421:30Business WireStoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:STOKStoke Therapeutics Inc
17/05/202421:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STOKStoke Therapeutics Inc
17/05/202421:12Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:STOKStoke Therapeutics Inc
06/05/202421:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:STOKStoke Therapeutics Inc
06/05/202412:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STOKStoke Therapeutics Inc
06/05/202412:00Business WireStoke Therapeutics Reports First Quarter Financial Results and Provides Business UpdatesNASDAQ:STOKStoke Therapeutics Inc
29/04/202413:00Business WireStoke Therapeutics Appoints Thomas Leggett as Chief Financial OfficerNASDAQ:STOKStoke Therapeutics Inc
17/04/202413:00Business WireStoke Therapeutics Appoints Jason Hoitt as Chief Commercial OfficerNASDAQ:STOKStoke Therapeutics Inc
04/04/202421:30Business WireStoke Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:STOKStoke Therapeutics Inc
28/03/202403:40Business WireStoke Therapeutics Announces Pricing of Upsized $125 Million Public OfferingNASDAQ:STOKStoke Therapeutics Inc
26/03/202420:07Business WireStoke Therapeutics Announces Proposed Public OfferingNASDAQ:STOKStoke Therapeutics Inc
25/03/202420:01Business WireStoke Therapeutics Announces Landmark New Data That Support the Potential for STK-001 to be the First Disease-Modifying Medicine for the Treatment of Patients with Dravet SyndromeNASDAQ:STOKStoke Therapeutics Inc
25/03/202420:01Business WireStoke Therapeutics Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:STOKStoke Therapeutics Inc
05/03/202421:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STOKStoke Therapeutics Inc
01/03/202421:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STOKStoke Therapeutics Inc
26/02/202415:38Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:STOKStoke Therapeutics Inc
26/02/202415:36Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:STOKStoke Therapeutics Inc
14/02/202414:20Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:STOKStoke Therapeutics Inc
05/02/202421:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STOKStoke Therapeutics Inc
01/02/202421:49Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STOKStoke Therapeutics Inc
17/01/202421:30Business WireStoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:STOKStoke Therapeutics Inc
08/01/202413:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STOKStoke Therapeutics Inc
08/01/202413:00Business WireStoke Therapeutics Highlights Strategic Priorities and Anticipated Milestones for 2024NASDAQ:STOKStoke Therapeutics Inc
04/01/202421:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STOKStoke Therapeutics Inc
04/01/202421:30Business WireStoke Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:STOKStoke Therapeutics Inc
02/01/202421:29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STOKStoke Therapeutics Inc
14/12/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STOKStoke Therapeutics Inc
05/12/202321:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STOKStoke Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:STOK

Your Recent History

Delayed Upgrade Clock